Tema Neuroscience and Mental Health ETF (MNTL) Holdings $23.81 +0.01 (+0.04%) Closing price 08/6/2025Extended Trading$23.81 0.00 (0.00%) As of 08/6/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 MNTL HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$395.12-0.6%10.36%2,2982REGNRegeneron Pharmaceuticals$589.48-1.5%8.12%1,4883ALNYAlnylam Pharmaceuticals$454.38-2.8%7.94%1,9824ARGXargenex$660.00-0.6%5.87%8905NBIXNeurocrine Biosciences$135.43+0.1%4.77%3,9046TEVATeva Pharmaceutical Industries$18.47-1.8%4.32%28,8617LLYEli Lilly and Company$710.73+0.1%4.02%5478CRNXCrinetics Pharmaceuticals$30.92+5.2%3.52%13,0669IONSIonis Pharmaceuticals$42.69-1.3%3.45%8,31810SYKStryker$393.80+2.3%3.19%877 Get the Latest News and Ratings for MNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. 11BIIBBiogen$139.31+0.1%3.16%2,50112MDTMedtronic$92.62+1.7%2.55%2,97613ACADACADIA Pharmaceuticals$25.74+3.9%2.43%10,59614UCB SAN/A2.43%1,19315AXSMAxsome Therapeutics$118.51+1.2%2.37%2,32716CPRXCatalyst Pharmaceuticals$21.08+2.5%2.36%11,35217DNLIDenali Therapeutics$15.49+1.7%2.09%15,17418XENEXenon Pharmaceuticals$38.84+1.7%1.94%6,11119RNAAvidity Biosciences$46.35+3.8%1.92%5,39220US DOLLARSN/A1.92%201,17421JAZZJazz Pharmaceuticals$123.11+2.1%1.85%1,67222SRRKScholar Rock$35.49+2.6%1.71%4,83623DXCMDexCom$82.26+2.0%1.62%2,23124PTCTPTC Therapeutics$50.57+3.4%1.56%3,12425ALKSAlkermes$29.75+2.4%1.51%5,940 Related Companies and Tools Related Companies FINE Holdings USRD Holdings BOTT Holdings BULD Holdings WNDY Holdings SPAM Holdings TEKX Holdings PTEC Holdings ARVR Holdings XDNA Holdings This page (NASDAQ:MNTL) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access